news Novo Nordisk partners with OpenAI as AI drug discovery hopes mount By AdminApril 14, 2026Less 1 min read36 Views0 The partnership will enable Novo to better use AI to analyze complex datasets, and identify promising new drugs. ShareTweetPinShare Previous PostAsia markets mostly higher amid hopes of a U.S.-Iran deal; China exports miss estimates Next PostEuropean markets rise on hopes that Iran peace talks can resume Leave a Reply Your email address will not be published. Required fields are marked * Save my name, email, and website in this browser for the next time I comment. You May Also Like April 10, 20260 Comments Homeland Security Workers Get Paid, but the Next Check Is Uncertain February 8, 20260 Comments 7 Days, No Suspects: The Disappearance of Nancy Guthrie June 6, 20260 Comments Newark Mayor to Scale Back Police Presence at Delaney Hall ICE Detention Center November 19, 20250 Comments Australian prisoner sues for right to eat Vegemite
June 6, 20260 Comments Newark Mayor to Scale Back Police Presence at Delaney Hall ICE Detention Center